INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Natera, Inc. (NTRA) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of Natera, Inc. (“Natera” or the “Company”) (NASDAQ: NTRA) investors concerning the Company’s possible violations of the federal securities laws.

On January 1, 2022, an article from the New York Times called into question the accuracy of certain prenatal tests, alleging that positive results on tests are incorrect approximately 85 percent of the time, and that patients who receive a positive result are supposed to pursue follow-up testing, which “can cost thousands of dollars, come with a small risk of miscarriage and can’t be performed until later in pregnancy.” On this news, Natera’s stock price fell $3.29, or 3.6%, to close at $88.04 per share on January 4, 2022, thereby injuring investors.

Then, on March 9, 2022, Hindenburg Research published a report which alleged, among other things, that Natera’s revenue growth has been “fueled by deceptive sales and billing practices aimed at doctors, insurance companies and expectant mothers.” On this news, Natera’s stock price fell $17.95, or 32.8%, to close at $36.80 per share on March 9, 2022, thereby further injuring investors.

Then, on March 14, 2022, a Delaware District Court jury found that Natera had engaged in false advertising. On this news, Natera’s stock price fell $5.57 per share, or 15.5%, to close at $30.32 per share on March 15, 2022, thereby further injuring investors.

If you purchased Natera securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at [phone], toll-free at [phone], or by email to [e-mail], or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.